Results
1 -
8 of
8Recent advances in the use of PI3K inhibitors for glioblastoma multiforme: current preclinical and clinical development, Molecular Cancer Targeting the PI3K/AKT/mTOR Pathway in Prostate Cancer, Management of Castration Resistant Prostate Cancer The skin and hair as surrogate tissues for measuring the target effect of inhibitors of phosphoinositide-3-kinase signaling, Cancer Chemotherapy and Pharmacology Protein and lipid kinase inhibitors as targeted anticancer agents of the Ras/Raf/MEK and PI3K/PKB pathways, Purinergic Signalling A multicenter phase 1 study of PX-866 and cetuximab in patients with metastatic colorectal carcinoma or recurrent/metastatic squamous cell carcinoma of the head and neck, Investigational New Drugs Targeting the PI3K/AKT/mTOR signaling pathway in glioblastoma: novel therapeutic agents and advances in understanding, Tumor Biology Phosphatidylinositol 3-kinase (PI3K) inhibitors as cancer therapeutics, Journal of Hematology & Oncology Targeting phosphoinositide 3-kinase (PI3K) in head and neck squamous cell carcinoma (HNSCC), Cancers of the Head & Neck